Thrombocytopenia as Type 1 ROP Biomarker: A Longitudinal Study
This study aimed to prospectively evaluate the association between the appearance and evolution of retinopathy of prematurity (ROP) and selected blood parameters, focusing on platelets count. In total, 157 preterm consecutive babies screened for ROP were included and classified in: ROP necessitating...
Main Authors: | Raffaele Parrozzani, Giulia Marchione, Alberto Fantin, Luisa Frizziero, Sabrina Salvadori, Daniel Nardo, Giulia Midena |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/11/1120 |
Similar Items
-
Platelet Counts and Risk of Severe Retinopathy of Prematurity: A Bayesian Model-Averaged Meta-Analysis
by: Mohamad F. Almutairi, et al.
Published: (2023-12-01) -
Thrombocytopenia as a Clinical Biomarker of Retinopathy of Prematurity
by: I Wayan Eka Sutyawan, et al.
Published: (2023-12-01) -
The association of platelet counts with development and treatment for retinopathy of prematurity – is thrombocytopenia a risk factor?
by: Aneta Choręziak, et al.
Published: (2019-05-01) -
Screening for ROP
by: Graham Quinn, et al.
Published: (2017-11-01) -
Chorioretinal Side Effects of Therapeutic Ocular Irradiation: A Multimodal Imaging Approach
by: Giulia Midena, et al.
Published: (2020-10-01)